BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Old Second Bancorp
OSBC
$1.31B
| $56.7K | ﹤0.01% |
4,636
+40
| +0.9% | +$496 |
|
3277
Carriage Services
CSV
$555M
| $56.5K | ﹤0.01% |
2,766
+10
| +0.4% | +$207 |
|
|
MOFG
3278
DELISTED
MidWestOne Financial Group
MOFG
| $56.1K | ﹤0.01% |
1,839
+11
| +0.6% | +$322 |
|
3279
Powell Industries
POWL
$7.43B
| $56.1K | ﹤0.01% |
4,299
-303
| -7% | -$3.77K |
|
3280
Future Fuel
FF
$249M
| $56.1K | ﹤0.01% |
4,696
-724
| -13% | -$8.25K |
|
|
LCI
3281
DELISTED
Lannett Company, Inc.
LCI
| $56K | ﹤0.01% |
1,250
-543
| -30% | -$18.5K |
|
|
NEX
3282
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $56K | ﹤0.01% |
9,238
+2,085
| +29% | +$12.2K |
|
3283
Ribbon Communications
RBBN
$377M
| $55.9K | ﹤0.01% |
9,576
-247
| -3% | -$1.3K |
|
3284
West Bancorporation
WTBA
$511M
| $55.9K | ﹤0.01% |
2,572
+187
| +8% | +$3.97K |
|
3285
Ezcorp Inc
EZPW
$1.76B
| $55.6K | ﹤0.01% |
8,621
-2,705
| -24% | -$23.2K |
|
|
ORBC
3286
DELISTED
ORBCOMM, Inc.
ORBC
| $55.6K | ﹤0.01% |
11,686
+3,512
| +43% | +$21K |
|
3287
Sterling Infrastructure
STRL
$16.9B
| $55.6K | ﹤0.01% |
4,230
+219
| +5% | +$2.68K |
|
|
RST
3288
DELISTED
ROSETTA STONE INC
RST
| $55.6K | ﹤0.01% |
3,195
+6
| +0.2% | +$121 |
|
|
PDLI
3289
DELISTED
PDL BioPharma, Inc.
PDLI
| $55.5K | ﹤0.01% |
25,682
+5,798
| +29% | +$15.5K |
|
|
IMGN
3290
DELISTED
Immunogen Inc
IMGN
| $55.5K | ﹤0.01% |
22,919
+7,064
| +45% | +$18.8K |
|
3291
Willdan Group
WLDN
$1.29B
| $55.4K | ﹤0.01% |
1,580
+421
| +36% | +$15K |
|
3292
Franklin Covey
FC
$227M
| $55.4K | ﹤0.01% |
1,583
+444
| +39% | +$16K |
|
3293
Greenlight Captial
GLRE
$512M
| $55.3K | ﹤0.01% |
5,268
-178
| -3% | -$1.68K |
|
|
ACR
3294
ACRES Commercial Realty
ACR
$101M
| $55.2K | ﹤0.01% |
1,617
-558
| -26% | -$19K |
|
3295
Collegium Pharmaceutical
COLL
$913M
| $55.1K | ﹤0.01% |
4,798
+1,512
| +46% | +$17.3K |
|
3296
RPC Inc
RES
$1.39B
| $55K | ﹤0.01% |
9,809
+7,356
| +300% | +$43.7K |
|
3297
Central Garden & Pet Co
CENT
$2.78B
| $55K | ﹤0.01% |
2,353
-62
| -3% | -$1.34K |
|
3298
Citizens
CIA
$198M
| $55K | ﹤0.01% |
8,000
-107
| -1% | -$748 |
|
|
NVO
3299
Novo Nordisk
NVO
$205B
| $55K | ﹤0.01% |
2,126
-108
| -5% | -$2.73K |
|
|
LGF.B
3300
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $54.9K | ﹤0.01% |
6,283
-172,560
| -96% | -$1.85M |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.